Blackstone, Corsair Capital looking to sell off First Eagle: report
Blackstone (NYSE:BX) and Corsair Capital are looking to sell First Eagle Investment Management for more than $4B, the Financial Times reported late Friday, citing people briefed on the matter.
pharmaphorum17h
Novartis gets FDA OK for first in its trio of IgAN therapies
Novartis has claimed accelerated approval ... while zigakibart is in phase 3. In 2021, Calliditas Therapeutics' corticosteroid-based Tarpeyo (budesonide) became the first FDA-approved therapy ...
Novartis15h
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis23h
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search. Notice to applicants for US job openings. Learn ...